ASXSF Elysee Development Corp (PK)

Remedent, Inc. (OTCBB: REMI), an international company specializing in oral care and cosmetic dentistry products, today announced that it has signed a sole selective distribution agreement with Thimar Al Jazirah, a well-known health care company in Saudi Arabia with a strong distribution network, for the marketing and distribution of Glamsmile�, a revolutionary cosmetic dental system that substantially expands the consumer and professional dental market for veneers. Thimar Al Jazirah agreed to a negotiated upfront initial payment and, in order to maintain its sole selective distributorship in the Saudi Arabian market, Thimar Al Jazirah further agreed to purchase and install a specified minimum number of Glamsmile� veneers in the first year of the agreement. Both the upfront payment and the minimum number of Glamsmile� installations were related to the size of the market opportunity. Mr. Guy De Vreese, Chairman of Remedent, commented, �We are very pleased to engage Thimar Al Jazirah as our marketing and distribution partner for Glamsmile� veneers in the Kingdom of Saudi Arabia. We believe Thimar Al Jazirah has one of the strongest sales and marketing teams in Saudi Arabia, supported by a head office in Riyadh, as well as two other branches covering the east and west regions of the country. This is our second distribution agreement in the Middle East and we continue to line up additional distribution agreements around the globe in order to market the Glamsmile� veneer technology in a timely manner and establish it as the veneer of choice by perceptive consumers.� About Thimar Al Jazirah Thimar Al Jazirah was founded in the 1970's and was active as a commercial organization in various fields. Responding to the demands of a fast developing healthcare sector in the Kingdom of Saudi Arabia, a new medical and healthcare division was established in the year 1980. The company continues to have direct and uninterrupted involvement of top management in its marketing and selling strategies and day-to-day implementation. The management has strived to make the medical & healthcare division a service oriented organization with realistic and productive strategies. About Remedent, Inc. Remedent, Inc., a publicly-traded company on the OTCBB, specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. With offices in California, Belgium and Singapore, Remedent distributes its products in more than 35 countries. For additional information, visit Remedent's web site at www.remedent.com. FORWARD-LOOKING STATEMENTS �Safe Harbor� Statement under the Private Securities Litigation Reform Act of 1995: The statements by Guy De Vreese, the statements regarding growth of the GlamsmileTM product line, optimism related to the business, expanding sales, the Saudi Arabian market�and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company�s business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company�s products. In addition, actual results could vary materially based on changes or slower growth in the oral care and cosmetic dentistry products market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in the dental industry; unexpected difficulties in penetrating the oral care and cosmetic dentistry products market; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company�s Securities and Exchange Commission filings under �risk factors� and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.